Boston Scientific SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 28, 2026, 6:34 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedBoston Scientific Q3 2026 adjusted EPS of $0.73 beats $0.72 consensus on $5.138 billion sales, but Q4 and full-year adjusted EPS guidance falls below consensus
8-KOct. 7, 2026, 6:11 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Other events · Financial statements and exhibits
8-KSept. 23, 2026, 6:01 a.m. ETView on SEC.gov
Departure/appointment of directors or officers
8-KSept. 8, 2026, 6:15 a.m. ETView on SEC.gov
Material cybersecurity incident
4Sept. 3, 2026, 4:34 p.m. ETView on SEC.gov
4Aug. 26, 2026, 6:46 p.m. ETView on SEC.gov
8-KAug. 26, 2026, 6:06 a.m. ETView on SEC.gov
Other events
4Aug. 12, 2026, 4:08 p.m. ETView on SEC.gov
4Aug. 11, 2026, 4:39 p.m. ETView on SEC.gov
4Aug. 7, 2026, 4:16 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 6, 2026, 10:17 a.m. ETView on SEC.gov
4Aug. 5, 2026, 4:15 p.m. ETView on SEC.gov
4Aug. 5, 2026, 4:15 p.m. ETView on SEC.gov
4Aug. 3, 2026, 4:29 p.m. ETView on SEC.gov
4Aug. 3, 2026, 4:29 p.m. ETView on SEC.gov
10-QAug. 3, 2026, 6:32 a.m. ETView on SEC.gov
8-KJuly 29, 2026, 6:33 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
8-KJuly 27, 2026, 4:06 p.m. ETView on SEC.gov
Costs of exit or disposal activities